C 745 Pill - yellow round, 6mm
Generic Name: repaglinide
Pill with imprint C 745 is Yellow, Round and has been identified as Prandin 1 mg. It is supplied by Gemini Laboratories, LLC.
Prandin is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Prandin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 745
Prandin
- Generic Name
- repaglinide
- Imprint
- C 745
- Strength
- 1 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gemini Laboratories, LLC
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
magnesium stearate,
silicon dioxide,
meglumine,
poloxamer 181,
ferric oxide yellow,
microcrystalline cellulose,
povidone,
corn starch,
croscarmellose sodium
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
60846-0882 (Discontinued) | |
57664-0745 | Caraco Pharmaceutical Laboratories, Ltd. |
42291-0719 (Discontinued) | AvKare, Inc. |
68084-0954 (Discontinued) | Amerisource Health Services |
Related images for "C 745"
More about Prandin (repaglinide)
- Check interactions
- Compare alternatives
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.